MarketPR
MARKETSPomerantz class action names ChampionX Corporation; CHX investors face upcoming deadlinesJul 16MARKETSArchy Revenue targets dental billing backlog with AI-powered payment postingJul 16MARKETSAmerica's 10 cheapest states for 2026: where cost of living still clears the inflation barJul 16MARKETSShareholder investigation opens into Silvaco Group (NASDAQ: SVCO) over potential fiduciary breachesJul 16MARKETSHorizon Trade Opens Waitlist for Agentic Equity and Crypto PlatformJul 16MARKETSFed July rate hike odds climb as oil jumps on Strait of Hormuz developmentsJul 16MARKETSApochromatik RealBD data prints more than $9.3 million in law firm revenue, 17,900% ROI in under 12 monthsJul 16MARKETSChubb Survey: 78% of Young Luxury Collectors Buy for Investment, Majority Carry No InsuranceJul 16MARKETSS&P Global Study: U.S. LNG on Pace for Second-Largest Net Export Industry Rank Within Five YearsJul 16MARKETSVirax Biolabs fiscal 2026 annual report lands with $6.4 million cash, Fosun Diagnostics supply deal on the boardJul 16MARKETSPomerantz class action names ChampionX Corporation; CHX investors face upcoming deadlinesJul 16MARKETSArchy Revenue targets dental billing backlog with AI-powered payment postingJul 16MARKETSAmerica's 10 cheapest states for 2026: where cost of living still clears the inflation barJul 16MARKETSShareholder investigation opens into Silvaco Group (NASDAQ: SVCO) over potential fiduciary breachesJul 16MARKETSHorizon Trade Opens Waitlist for Agentic Equity and Crypto PlatformJul 16MARKETSFed July rate hike odds climb as oil jumps on Strait of Hormuz developmentsJul 16MARKETSApochromatik RealBD data prints more than $9.3 million in law firm revenue, 17,900% ROI in under 12 monthsJul 16MARKETSChubb Survey: 78% of Young Luxury Collectors Buy for Investment, Majority Carry No InsuranceJul 16MARKETSS&P Global Study: U.S. LNG on Pace for Second-Largest Net Export Industry Rank Within Five YearsJul 16MARKETSVirax Biolabs fiscal 2026 annual report lands with $6.4 million cash, Fosun Diagnostics supply deal on the boardJul 16
NewsMacro

Pomerantz class action names ChampionX Corporation; CHX investors face upcoming deadlines

A securities class action against ChampionX Corporation (NASDAQ: CHX) is in focus after Pomerantz LLP announced it has filed suit on behalf of investors who recorded losses on their holdings in the company. The New York law firm issued its reminder on July 16, 2026. Upcoming deadlines for affected shareholders to participate are now the next definitive date on the tape.

By Elias VanceMacro DeskJuly 16, 20262 min read
Share

A securities class action against ChampionX Corporation (NASDAQ: CHX) is in focus after Pomerantz LLP announced it has filed suit on behalf of investors who recorded losses on their holdings in the company. The New York law firm issued its reminder on July 16, 2026. Upcoming deadlines for affected shareholders to participate are now the next definitive date on the tape.

The action

Pomerantz LLP is targeting investors who suffered losses on ChampionX stock and is soliciting shareholders who believe they qualify to step forward before the relevant filing deadline. That deadline has not been disclosed in this release. Direct contact with the firm is the fastest way to confirm the window.

Securities class actions allow investors with similar claims to pursue them collectively. Participation deadlines in these cases typically determine who can take an active role in the litigation as it proceeds.

How to reach Pomerantz

The firm is directing interested CHX investors to Danielle Peyton. She is reachable at [email protected] or by phone at 646-581-9980. Investors who believe their ChampionX losses qualify them should not wait for additional notices before making contact.

What to watch

The upcoming filing deadline is the next concrete marker for CHX holders following this development. How many investors file and what role they take will shape the litigation's early direction. For shareholders who recorded losses on ChampionX and have not yet reviewed their options, the Pomerantz contact window is the date to track.

About this story

Filed by the macro desk of MarketPR on July 16, 2026. Source: MarketPR. Indicative figures are not investment advice.

←Back to the news index

More from the Newsroom

All stories →
01Macro

Archy Revenue targets dental billing backlog with AI-powered payment posting

Insurance payment posting sits at the friction point in dental practice cash cycles. San Jose-based Archy moved on Wednesday to automate it with Archy Revenue, a paid upgrade built inside the existing Archy platform that applies AI to process routine insurance remittances and fla

Mara Whitfield2 min read
02Macro

America's 10 cheapest states for 2026: where cost of living still clears the inflation bar

A cost-of-living ranking identifies 10 states where residents in 2026 can still beat inflation. The list focuses on affordability at the state level: where living costs remain low enough that [household purchasing

Elias Vance2 min read
03Macro

Shareholder investigation opens into Silvaco Group (NASDAQ: SVCO) over potential fiduciary breaches

A shareholder investigation is now in focus for Silvaco Group, Inc. (NASDAQ: SVCO) after New York law firm Purcell & Lefkowitz LLP announced July 16, 2026 that it is examining whether the c

Ines Ferreira2 min read

Key takeaways

Frequently asked

Who filed the class action and against whom?

Pomerantz LLP, a New York law firm, filed the securities class action against ChampionX Corporation (NASDAQ: CHX) on behalf of investors who suffered losses on their holdings.

What is the deadline for shareholders to participate?

The specific filing deadline has not been disclosed in this release; investors are advised to contact the firm directly to confirm the window.

How can affected investors reach Pomerantz?

Interested CHX investors can contact Danielle Peyton at [email protected] or by phone at 646-581-9980.

Who is eligible to participate in the action?

Investors who recorded losses on their ChampionX stock and believe they qualify are being solicited to step forward before the relevant filing deadline.

What should CHX holders watch for next?

The upcoming filing deadline is the next concrete marker, as the number of investors who file and the roles they take will shape the litigation's early direction.